Disruption of fkbp3 significantly increases the resistance of A. flavus to rapamycin and FK506
(A) Phenotype of the WT and all mutant strains (Δfkbp1, Δfkbp2, Δfkbp3, and Δfkbp4) grown on PDA amended with rapamycin and FK506 at 37°C for 5 days.
(B) TLC analysis of AFB1 production by the WT and all mutant strains (Δfkbp1, Δfkbp2, Δfkbp3, and Δfkbp4) cultured in YES liquid medium at 29°C for 6 days.
(C) The growth inhibition rate of the WT and all mutant strains (Δfkbp1, Δfkbp2, Δfkbp3, and Δfkbp4) under rapamycin and FK506 stress.
(D) AFB1 quantitative analysis of the WT and all mutant strains (Δfkbp1, Δfkbp2, Δfkbp3, and Δfkbp4) as described in (B).
(E) Phenotype of the WT and all mutant strains (Δfkbp3, K5A, K19A, K40A, K42A, K55A, and K65A) grown on PDA amended with 100 ng/mL rapamycin at 37°C for 5 days.
(F) The growth inhibition rate of the WT and all mutant strains (Δfkbp3, K5A, K19A, K40A, K42A, K55A, and K65A) under rapamycin stress.
(G) TLC assay of AFB1 production by the WT and all mutant strains (Δfkbp3, K5A, K19A, K40A, K42A, K55A, and K65A) cultured in YES liquid medium at 29°C for 6 days.
(H) Relative quantification of AFB1 production in the WT and all mutant strains (Δfkbp3, K5A, K19A, K40A, K42A, K55A, and K65A) as mentioned in (G).